Jayesh and Why Kenya needs a trustworthy Healthcare industry

Kenya has seen two vaccines namely AstraZeneca, from Serum Institute of India and Sputnik, from the Gamaleya Research Institute. Whilst Sputnik was imported by Dinlas Pharmaceuticals, it was re-exported due to administrative issues.

Dinlas Pharmaceuticals had prepared themselves for the vaccination drive by having strategies in place for fair distribution and assistance in the administration of the Sputnik vaccine. Nurses and healthcare staff across the partner companies of Mr. Jayesh Saini, Kenya; like Bliss Healthcare, Nairobi West Hospital, Clinix Healthcare etc. were specifically trained to administer the jabs manage the mass volume of patients.

In July, Dinlas Pharma EPZ Limited sued NMG and want the court to order them to pay them court filing fees and a permanent injunction restraining them from further publishing words that are defamatory to the firm.

Dinlas Pharma EPZ Limited claims that it has suffered losses of $45 million (Sh4.8 billion), following ‘COVID Millionaires’ publication in a local daily owned by NMG. Dinlas says as a consequence of the printing and publication, its business reputation has been seriously damaged and brought into public scandal.

Through lawyer Donald Kipkorir, the company issued a cease and demand notice dated April 7 to NMG and team but they have refused and neglected to respond.

“We are apprehensive that unless injucted, the defendants shall and threaten to continue publication of same or similar defamatory words,” it says.

Dinlas entered into a contract to import Sputnik V vaccine from Russia via Dubai. The importation was to be in two batches of 75,000 and 1 million doses. The company further entered into a distribution agreement with Harleys Limited, a pharmaceutical distributor within Kenya.

“We applied for and received all approvals for the said importation,” it says.

According to court documents, the publication on April 2 portrayed Dinlas as a corrupt company intending to defraud the public.

Dinlas Pharma EPZ Limited is a pharmaceutical manufacturing facility located on Plot No. 7149/121 along Mombasa Road at Syokimau. This is 9 kilometres from Jomo Kenyatta International Airport and 20 kilometers from Nairobi Capital City, Kenya.

This facility is designed to manufacture, pack, analyze, store and distribute various pharmaceutical dosage forms, namely.

• Solid Dosage Forms (Tablets and Capsules)
• Liquid Dosage Forms (Syrups and Suspensions)
• Topical Preparations (Creams and Ointments)

This was done and signed off by Ministry of Health (MOH) / Afya house medical team. Mr. Jayesh Saini touched upon his vision behind establishing the state-of-the-art RnD department at Dinlas Pharmaceuticals LTD recently. In addition to having top-notch manufacturing and packaging machines – it’s equally important to have the above to encourage the team to continue the trials for new molecules 24/7. This remains paramount for the continuously evolving journey of a well-established pharmaceutical setup.

Kenya will benefit from a new $7.7 billion (Sh800 billion) global effort to fight Covid-19 and carry out a study on emerging variants.

The fundraising appeal is led by the Access to Covid-19 Tools Accelerator (ACT-Accelerator), a global coalition of groups developing and deploying the new diagnostics, treatments and vaccines needed to end the acute phase of the pandemic.

“With more Covid-19 cases reported in the first five months of 2021 than in the whole of 2020, the world is still in the acute phase of the pandemic,” the World Health Organization, an Act-Accelerator partner, said in a statement.